Julie S. Townsend, MS; Stephanie C. Melkonian, PhD; Melissa A. Jim, MPH; et al.
JAMA Dermatol. 2024;160(2):148-155. doi:10.1001/jamadermatol.2023.5226
This cross-sectional study examines invasive cutaneous melanoma incidence rates and trends over time among non-Hispanic American Indian/Alaska Native people.
Lawrence F. Eichenfield, MD; Sanela Tarabar, MD, MPH; Seth Forman, MD; et al.
open access
JAMA Dermatol. 2024;160(2):156-163. doi:10.1001/jamadermatol.2023.4990
This phase 2a randomized clinical trial assesses the efficacy, safety, tolerability, and pharmacokinetics of topical PF-07038124 in patients with mild to moderate atopic dermatitis or plaque psoriasis.
Sarah Gold, BA; Meron Siira, MPH; Sigal Willner, MD, MPH; et al.
has audio
JAMA Dermatol. 2024;160(2):164-171. doi:10.1001/jamadermatol.2023.5355
This mixed-methods study examines the lived experiences of acne and acne treatment in transgender and gender-diverse individuals.
-
Audio:
Lived Experience of Acne and Acne Treatment in Transgender Patients
Noreen Mohsin, MD; Devin Hunt, BS, BSM; Jia Yan, MS, PhD, CGC; et al.
JAMA Dermatol. 2024;160(2):172-178. doi:10.1001/jamadermatol.2023.5362
This case-control study examines genetic risk factors associated with early-onset Merkel cell carcinoma.
Nicole Salame, MD; Yacine N. Sow, BA; Meron R. Siira, MPH; et al.
JAMA Dermatol. 2024;160(2):179-186. doi:10.1001/jamadermatol.2023.5425
This qualitative study examines factors that patients with hidradenitis suppurativa consider when deciding about new treatments.
Martin Metz, MD; Claudia Zeidler, MD; Tomasz Hawro, MD; et al.
JAMA Dermatol. 2024;160(2):187-193. doi:10.1001/jamadermatol.2023.5519
This qualitative study develops and validates the Prurigo Control Test, a tool for assessing disease control in chronic prurigo, and identifies a cutoff value for controlled disease to aid treatment decisions.